SCHEMBL29574792

SCHEMBL29574792

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@@H](O)COP(=O)(O)OCCN

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.59
P2RY10 O00398 6/20 0.57
GPR174 Q9BXC1 6/20 0.57
GPR34 Q9UPC5 3/20 0.57
LPAR1 Q92633 6/20 0.54
ENPP2 Q13822 2/20 0.54
LPAR4 Q99677 2/20 0.54
LPAR5 Q9H1C0 2/20 0.54
LPAR2 Q9HBW0 2/20 0.54
LPAR3 Q9UBY5 2/20 0.54
CES2 O00748 1/20 0.54
LPAR6 P43657 1/20 0.54
TRPV1 Q8NER1 1/20 0.54
SELP P16109 1/20 0.53
FAAH O00519 2/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
THRB P10828 1/20 0.51
CNR1 P21554 1/20 0.51
NR1I2 O75469 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29885995 1.00 GPR55 (0.59) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL29666841 1.00 GPR55 (0.59) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL31442312 0.97 P2RY10 (0.61) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL29373089 0.96 P2RY10 (0.63) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL29666872 0.96 P2RY10 (0.63) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL29653971 0.96 P2RY10 (0.63) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL29484972 0.96 P2RY10 (0.63) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL29666833 0.96 P2RY10 (0.63) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL29614897 0.96 P2RY10 (0.63) GPR55P2RY10GPR174GPR34LPAR1
SCHEMBL26485899 0.96 P2RY10 (0.63) GPR55P2RY10GPR174GPR34LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120703380-B Gestational diabetes diagnosis marker combination and application thereof, kit, device and assessment model 重庆医科大学 2026-05-12 CN claimed
US-20250020675-A1 Application of Lipid Biomarkers in Diagnosis and Early Warning of Fatty Liver in Periparturient Dairy Cows SHANDONG AGRICULTURAL UNIVERSITY (CN) 2025-01-16 US claimed
CN-118777442-A Lung cancer lipid marker, application thereof and lung cancer specific diagnostic kit 复旦大学附属中山医院 2024-10-15 CN claimed
CN-118731242-A Application of lipid biomarker in diagnosis and early warning of fatty liver of perinatal dairy cows 山东农业大学 2024-10-01 CN claimed
CN-117110453-A Application of lipid biomarker in diagnosis and early warning of fatty liver of perinatal dairy cows 山东农业大学 2023-11-24 CN claimed
CN-120703380-B Gestational diabetes diagnosis marker combination and application thereof, kit, device and assessment model 重庆医科大学 2026-05-12 CN disclosed
CN-120703380-B Gestational diabetes diagnosis marker combination and application thereof, kit, device and assessment model 重庆医科大学 2026-05-12 CN disclosed
CN-120703380-A Gestational diabetes diagnosis marker combination and application thereof, kit, device and assessment model 重庆医科大学 2025-09-26 CN disclosed
US-20250166821-A1 METHODS FOR PREDICTION OF TREATMENT RESPONSE IN NON-ALCOHOLIC FATTY LIVER DISEASE SAGIMET BIOSCIENCES INC. 2025-05-22 US disclosed
US-20250020675-A1 Application of Lipid Biomarkers in Diagnosis and Early Warning of Fatty Liver in Periparturient Dairy Cows SHANDONG AGRICULTURAL UNIVERSITY (CN) 2025-01-16 US disclosed
CN-118777442-A Lung cancer lipid marker, application thereof and lung cancer specific diagnostic kit 复旦大学附属中山医院 2024-10-15 CN disclosed
CN-118731242-A Application of lipid biomarker in diagnosis and early warning of fatty liver of perinatal dairy cows 山东农业大学 2024-10-01 CN disclosed
CN-117110453-A Application of lipid biomarker in diagnosis and early warning of fatty liver of perinatal dairy cows 山东农业大学 2023-11-24 CN disclosed
US-20230305027-A1 METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES GENENTECH INC (US) 2023-09-28 US disclosed
CN-116448910-A Method for preparing cancer diagnosis kit by lipid and application thereof 复旦大学附属中山医院 2023-07-18 CN disclosed
EP-4003305-A1 TOPICAL EXOSOME COMPOSITIONS AND ASSOCIATED METHODS Erivan Bio, LLC (US) 2022-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250166821-A1 METHODS FOR PREDICTION OF TREATMENT RESPONSE IN NON-ALCOHOLIC FATTY LIVER DISEASE ACACB, ACACA, ACLY GPR55 1722/4885P2RY10 3048/4885GPR174 3060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.